Sort
48,018 grants matching “immunotherapy”
Personalized Immunotherapy of Patients with Ovarian Cancer
$625,397Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2018 · CA
GPC2 CARs in neuroblastoma: Mechanisms of resistance and efficacy of next-generation constructs
$625,372Kristopher R Bosse · Children'S Hosp Of Philadelphia · R37 · FY2025 · CA
Molecular Imaging of Novel Immuno-therapy and Targeted Therapies for Malignant...
$625,367Antoni Ribas · University Of California Los Angeles · P50 · FY2011 · CA
MYCN drives a ferroptotic vulnerability in neuroblastoma
$625,334Anthony Charles Faber · Virginia Commonwealth University · R01 · FY2024 · CA
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)
$625,319Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$625,207Kim Butts Pauly · Stanford University · R01 · FY2020 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$625,160Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$625,110William E Gillanders · Washington University · R01 · FY2023 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$625,095William E Gillanders · Washington University · R01 · FY2022 · CA
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$625,074Cheng Zhu · Georgia Institute Of Technology · U01 · FY2019 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$625,024Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$624,971Gerald V Denis · Boston University Medical Campus · R01 · FY2019 · CA
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells
$624,970Robbie B Mailliard · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Processed Antigen Characterization by Mass Spectrometry
$624,957Donald F Hunt · University Of Virginia · R01 · FY2016 · AI
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
$624,955William E. Van Nostrand · University Of Rhode Island · R01 · FY2022 · NS
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$624,921Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Mechanistic Core
$624,908Lloyd F Mayer · Icahn School Of Medicine At Mount Sinai · U19 · FY2011 · AI
Rational translation of gold nanoparticle mediated radiosensitization to the clinic
$624,904Sunil Krishnan · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Development
$624,895Ana M Navarro · University Of California, San Diego · U54 · FY2008 · CA
Regulation of T cell exhaustion via 3D chromatin architecture
$624,855Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2025 · AI
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers
$624,800Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2022 · CA
Targeting neuroblastoma cell state plasticity
$624,652William A Weiss · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Engineering T Cell Adoptive Therapy for Glioblastoma
$624,543Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2024 · NS
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$624,529Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach
$624,441Kord Michael Kober · University Of California, San Francisco · R37 · FY2024 · CA